Nitrosoureas from chemist to physician: Classification and recent approaches to drug design
- 1 March 1990
- journal article
- review article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 26 (3) , 207-221
- https://doi.org/10.1016/0277-5379(90)90214-e
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Inhibition of the hepatic o6-alkylguanine-DNA alkyltransferase in vivo by pretreatment with antineoplastic agentsBiochemical Pharmacology, 1989
- Importance of the DNA repair enzyme O6-alkyl guanine alkyltransferase (AT) in cancer chemotherapyCancer Treatment Reviews, 1988
- Quantum chemical studies of the products of decomposition of anticancer (2-haloethyl)nitrosoureas under physiological conditionsJournal of the American Chemical Society, 1988
- Preferential alkylation by 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) of guanines with guanines as neighboring bases in DNABiochemical Pharmacology, 1988
- Qualitative and quantitative analysis of a new sulphur-containing nitrosourea in blood by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1987
- Cellular and molecular mechanisms of the bone marrow sparing effects of the glucose chloroethylnitrosourea chlorozotocinBlood, 1984
- A new class of nitrosoureas. 4. Synthesis and antitumor activity of disaccharide derivatives of 3,3-disubstituted 1-(2-chloroethyl)-1-nitrosoureasJournal of Medicinal Chemistry, 1982
- Phase I study of GANU and MCNUCancer Treatment Reviews, 1980
- Comparative pharmacology of three new nitrosourea analogues: RFCNU, RPCNU, and chlorozotocinCancer Chemotherapy and Pharmacology, 1979
- The Synthesis of Antineoplastic Agents. XXXII. N-Nitrosoureas.1 I.Journal of Medicinal Chemistry, 1963